Speakers: Ragnar Pitla (Microsoft) & Thomas Van Dorpe (Cegeka)

Operationalizing AI requires moving from tactical pilots to enterprise-wide industrialization. We will discuss the infrastructure necessary to transition from experimental chatbots to high-utility agents that automate complex workflows and drive measurable ROI across the entire pharmaceutical value chain. 

Speakers: Thomas Van Dorpe (Cegeka) & Joris Vandaele (Cegeka)

How can AI help finance teams work more efficiently and save time?
AI automates month‑end accruals, reduces manual effort in financial reporting, continuously updates customer credit ratings by analysing financial and behavioral data in real time, and supports audits by detecting anomalies and flagging compliance risks. Together, these AI agents are transforming finance operations across three critical pillars: accuracy, risk management, and compliance.  

Speaker: Sebastian Andersen (ClarityNorth Partners)

How pharma companies are navigating today's pressures from pricing strategy and supply chain shifts to capital allocation while bridging the gap between political rhetoric and economic reality. Using insights from 2025 M&A and capital markets activity, it will look at how policy uncertainty is changing dealmaking and what to expect as these dynamics continue to shape strategy and investment through 2026 and beyond.

Speaker: Allyson M. Maur ( McGuireWoods)

Entering the US market for Pharma and MedTech goes beyond choosing the right FDA pathway. Your choice affects how you design your quality system, manage suppliers, validate software, and prepare for audits on both sides of the Atlantic. In this session, legal experts walk through the practical implications of current and upcoming FDA expectations for Pharma and MedTech manufacturers, connecting the legal and regulatory view of risk with the ERP and business software view of execution. Learn how to turn compliance pressure into a predictable go-to-market journey.

Speaker: Chad Alessi (CTG)

AI adoption is changing the risk landscape across Pharma and MedTech, introducing threats that existing cybersecurity frameworks were never designed to address, from data leakage and prompt injection to overreliance on automated outputs.

This session focuses on how organizations can systematically identify, prioritize, and manage AI‑related risks based on how AI is actually being used across the enterprise, including sanctioned tools, embedded AI capabilities, and shadow AI. It examines how risk management needs to evolve from point‑in‑time assessments to continuous visibility, monitoring, and governance.

Drawing on real‑world usage patterns and industry data, the discussion highlights common challenges, emerging risk trends, and practical ways to integrate AI risk management into existing cybersecurity, compliance, and enterprise risk frameworks.

Speakers: Jacob Whitlow (Truvio) & Jørgen Bach (Truvio)

Pharmaceutical distributors often rely on disconnected systems for inventory, controlled substance compliance, DSCSA traceability, and customer-specific pricing. In this session, Jørgen Bach and Jacob Whitlow from Truvio Commerce, powered by DynamicWeb, will walk through the distribution challenges pharma companies face today and show how a purpose-built commerce and portal layer, natively connected to Dynamics 365, replaces that patchwork with a unified, compliant ordering experience. The session includes a product walkthrough, and Jørgen and Jacob will be available afterward to continue the conversation.